1. Home
  2. ASRT vs CODA Comparison

ASRT vs CODA Comparison

Compare ASRT & CODA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASRT
  • CODA
  • Stock Information
  • Founded
  • ASRT 1995
  • CODA 1994
  • Country
  • ASRT United States
  • CODA United States
  • Employees
  • ASRT N/A
  • CODA N/A
  • Industry
  • ASRT Biotechnology: Pharmaceutical Preparations
  • CODA Industrial Machinery/Components
  • Sector
  • ASRT Health Care
  • CODA Industrials
  • Exchange
  • ASRT Nasdaq
  • CODA Nasdaq
  • Market Cap
  • ASRT 78.3M
  • CODA 92.5M
  • IPO Year
  • ASRT 1997
  • CODA N/A
  • Fundamental
  • Price
  • ASRT $0.84
  • CODA $7.89
  • Analyst Decision
  • ASRT Strong Buy
  • CODA Strong Buy
  • Analyst Count
  • ASRT 4
  • CODA 1
  • Target Price
  • ASRT $3.19
  • CODA $11.00
  • AVG Volume (30 Days)
  • ASRT 341.2K
  • CODA 30.1K
  • Earning Date
  • ASRT 03-10-2025
  • CODA 03-17-2025
  • Dividend Yield
  • ASRT N/A
  • CODA N/A
  • EPS Growth
  • ASRT N/A
  • CODA 14.29
  • EPS
  • ASRT N/A
  • CODA 0.32
  • Revenue
  • ASRT $125,763,000.00
  • CODA $20,316,161.00
  • Revenue This Year
  • ASRT N/A
  • CODA $31.72
  • Revenue Next Year
  • ASRT $1.84
  • CODA $12.23
  • P/E Ratio
  • ASRT N/A
  • CODA $24.66
  • Revenue Growth
  • ASRT N/A
  • CODA 4.98
  • 52 Week Low
  • ASRT $0.73
  • CODA $5.48
  • 52 Week High
  • ASRT $1.80
  • CODA $9.89
  • Technical
  • Relative Strength Index (RSI)
  • ASRT 50.64
  • CODA 44.05
  • Support Level
  • ASRT $0.78
  • CODA $7.75
  • Resistance Level
  • ASRT $0.88
  • CODA $8.58
  • Average True Range (ATR)
  • ASRT 0.03
  • CODA 0.29
  • MACD
  • ASRT 0.01
  • CODA 0.00
  • Stochastic Oscillator
  • ASRT 61.60
  • CODA 16.87

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

About CODA Coda Octopus Group Inc. Common stock

Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. It operates in two segments: Marine Technology Business and Marine Engineering Business. The Technology Business develops proprietary solutions for both the commercial and defense subsea market. Its solutions include hardware and software for Geophysical Systems, Motion & Positioning Systems, and Real-Time Volumetric Imaging Sonar. The Engineering Business segment provides engineering services to a range of clients in the defense markets. Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Marine Technology Business segment.

Share on Social Networks: